KAISER PETER (Chief Development Officer) sold 4.7% of their position (9.65K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $106.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/6/2025ACC: 0001104659-25-097165
Officer· Chief Development Officer
Since Feb 2026
-9.65K
Net shares
Net seller
$106.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.65K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.65K
Price / share
$11.03
Trade value
$106.47K
% of position
4.7%
10/2/2025
204.09K→194.44K
Total
Net shares
−9.65K
Net value
-$106.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2025 | S · Sale | −9.65K | $11.03 | $106.47K | 4.7% | 204.09K | 194.44K |
| Total | −9.65K | -$106.47K | ||||||
Derivative Transactions0
No derivative transactions reported